Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke
Table 3
Factors associated with high D-dimer levels.
D-dimer ≥10 μg/mL after treatment
No
Yes
Male sex
18 (58.1%)
10 (47.6%)
0.458
Age, years
63 (55–71)
63 (55–70)
0.970
DWI patterns
0.724
Single vascular territory
6 (19.4%)
3 (14.3%)
Single lesion
3
2
Multiple lesions
3
1
Multiple vascular territories
25 (80.6%)
18 (85.7%)
Treatment
0.002
Enoxaparin
21 (67.7%)
5 (23.8%)
Warfarin
10 (32.3%)
16 (72.6%)
Cancer profiles
Primary cancer type
0.586
Lung
15 (48.4%)
12 (57.1%)
Gastrointestinal
4 (12.9%)
3 (14.3%)
Hepatobiliary
5 (16.1%)
5 (23.8%)
Breast-gynecologic
4 (12.9%)
1 (4.8%)
Other
3 (9.7%)
0 (0%)
Systemic metastasis
23 (74.2%)
20 (95.2%)
0.067
Adenocarcinoma
19 (61.3%)
17 (85.0%)
0.070
Other factors including vascular risk factors, premedications, and laboratory findings (platelet and fibrinogen) did not differ between the two groups ().
